Clinical Trial Update: Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing topical tacrolimus 0.03% versus cyclosporine 0.05% in dry eye associated with Sjogren syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye
• Sjogren Syndrome

Drugs mentioned

• Cyclosporine 0.05%
• Tacrolimus 0.03% (tacrolimus)

Snippet

Sponsor: Pavly Moawd | Conditions: Dry Eye, Sjogren Syndrome | Phase 3 | Status: COMPLETED